Monopar Therapeutics (MNPR) Financials: Revenue & Earnings

MNPR price $70.82 -1.02 -1.42%

Ticker
MNPR
Price
$70.82
Change
-1.02 -1.42%
Market cap ?
$475.36M
P/E ?
-30.19
Forward P/E ?
113.18
Dividend yield ?
0.00%
Beta ?
1.51
Sector
Healthcare
Industry
Biotechnology

Financials

2016201720182019202020212022202320242025
0000000000

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase…

Fair value

MNPR fair value $24.46. Price $70.82. Price is 190% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare MNPR

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.86——
2026-08-12-0.62-0.64——
2026-05-14-0.46-1.06——
2026-03-27-0.61-0.51——
2025-11-13-0.48-0.46——
2025-08-12-0.35-0.47——
2025-05-13-0.38-0.65——
2025-03-31-2.23-0.36——
2024-11-08-0.37-0.46——
2024-08-09-0.50-0.45——
2024-05-09-0.50-0.85——
2024-03-28-0.60-0.85——
2023-11-09-0.70-0.95——
2023-08-10-0.80-0.95——
2023-05-11-0.95-1.00——
2023-03-23-1.10-1.05——
2022-11-10-0.95-1.15——
2022-08-11-0.22-0.21——
2022-05-12-0.95-1.20——
2022-03-24-0.21-0.19——
2021-11-12-1.00-1.10——
2021-08-12-0.85-1.05——
2021-05-13-0.80-1.10——
2021-03-25-0.95-0.75——
2020-11-12-1.35-0.75——
2020-08-06-0.70-1.25——
2020-05-07-0.50-0.11——
2020-03-27-0.13-0.07——
2019-12-23-0.07———
2019-08-08-0.09———
2019-05-10-0.15———
2019-02-26-0.09———
2018-11-09-0.07———
2018-08-09-0.09———
2018-05-11-0.08———
2018-03-26-0.07———
2017-09-30-1.43———
2017-06-30-0.06———
2017-03-31-0.04———
2016-12-31-0.03———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-20Robinson ChandlerSell597$92.5955.28K
2026-10-01STARR CHRISTOPHER MBuy8.40K$0.0142
2026-10-01STARR CHRISTOPHER MSell4.63K$78.09361.63K
2026-10-01STARR CHRISTOPHER MSell8.40K$0.0142
2026-10-01STARR CHRISTOPHER MSell2.97K$78.82234.10K
2026-10-01STARR CHRISTOPHER MSell799$79.6763.66K
2026-09-30Cittadine AndrewBuy4.38K——
2026-09-30Cittadine AndrewSell1.94K$79.67154.88K
2026-09-30Cittadine AndrewSell4.38K——
2026-09-30Robinson ChandlerBuy9.80K——
2026-09-30Robinson ChandlerSell4.34K$79.67346.09K
2026-09-30Robinson ChandlerSell9.80K——
2026-09-30Vu Quan AnhSell614——
2026-09-30Vu Quan AnhBuy614——
2026-09-30Vu Quan AnhSell180$79.6714.34K
2026-09-24Robinson ChandlerBuy15.00K$14.00210.00K
2026-09-24Robinson ChandlerSell10.45K$87.15910.72K
2026-09-24Robinson ChandlerBuy14.06K$30.00421.68K
2026-09-24Robinson ChandlerSell9.64K$87.96847.76K
2026-09-24Robinson ChandlerSell8.37K$88.97744.50K
2026-09-24Robinson ChandlerSell600$89.7953.87K
2026-09-24Robinson ChandlerSell15.00K$14.00210.00K
2026-09-24Robinson ChandlerSell14.06K$30.00421.68K
2026-08-26Tsuchimoto Kim RBuy2.04K$14.0028.49K
2026-08-26Tsuchimoto Kim RBuy2.06K$30.0061.65K
2026-08-26Tsuchimoto Kim RBuy2.04K$14.0028.49K
2026-08-26Tsuchimoto Kim RSell485$108.8352.78K
2026-08-26Tsuchimoto Kim RSell615$109.5667.38K
2026-08-26Tsuchimoto Kim RSell700$110.6577.45K
2026-08-26Tsuchimoto Kim RBuy2.06K$30.0061.65K
2026-08-26Tsuchimoto Kim RSell1.10K$111.84122.80K
2026-08-26Tsuchimoto Kim RSell602$112.9367.98K
2026-08-26Tsuchimoto Kim RSell590$113.8467.17K
2026-08-26RIOUX PATRICEBuy1.38K$0.017
2026-08-26RIOUX PATRICESell1$111.26111
2026-08-26RIOUX PATRICEBuy1.38K$0.017
2026-08-26Tsuchimoto Kim RSell485$108.8352.78K
2026-08-26Tsuchimoto Kim RSell615$109.5667.38K
2026-08-26Tsuchimoto Kim RSell700$110.6577.45K
2026-08-26Tsuchimoto Kim RSell1.10K$111.84122.80K
2026-08-26Tsuchimoto Kim RSell602$112.9367.98K
2026-08-26Tsuchimoto Kim RSell590$113.8467.17K
2026-08-25Anderson RaymondBuy1.74K$30.0052.20K
2026-08-25Anderson RaymondSell694$110.0476.37K
2026-08-25Anderson RaymondSell646$111.0771.75K
2026-08-25Anderson RaymondBuy1.40K$30.0042.06K
2026-08-25Anderson RaymondSell1.80K$113.05203.72K
2026-08-25Anderson RaymondBuy1.74K$30.0052.20K
2026-08-25Anderson RaymondBuy1.40K$30.0042.06K
2026-08-25Anderson RaymondSell694$110.0476.37K
2026-08-25Anderson RaymondSell646$110.0771.11K
2026-08-25Anderson RaymondSell1.80K$113.05203.72K
2026-06-30Vu Quan AnhSell1.23K——
2026-06-30Vu Quan AnhBuy1.23K——
2026-06-30Vu Quan AnhSell507$92.5946.94K
2026-06-30Robinson ChandlerBuy12.87K——
2026-06-30Robinson ChandlerSell4.08K$92.59378.14K
2026-06-30Robinson ChandlerSell12.87K——
2026-06-30Cittadine AndrewBuy5.25K——
2026-06-30Cittadine AndrewSell2.31K$92.59213.79K
2026-06-30Cittadine AndrewSell5.25K——
2026-06-26Sweeny NicoleBuy1.28K$87.68112.58K
2026-06-22Sweeny NicoleOther0——
2026-03-31Robinson ChandlerSell6.73K——
2026-03-31Robinson ChandlerBuy6.73K——
2026-03-31Robinson ChandlerSell1.97K$54.79108.05K
2026-03-31Cittadine AndrewBuy3.51K——
2026-03-31Cittadine AndrewSell1.57K$54.7986.08K
2026-03-31Cittadine AndrewSell3.51K——
2026-03-02Rodriguez SusanBuy48.73K$53.472.61M
2026-03-02Rodriguez SusanOther0——
2026-01-01RIOUX PATRICEBuy2.00K$65.30130.60K
2025-12-31Robinson ChandlerSell8.72K——
2025-12-31Robinson ChandlerBuy8.72K——
2025-12-31Robinson ChandlerSell2.56K$65.30167.04K
2025-12-31Cittadine AndrewBuy4.33K——
2025-12-31Cittadine AndrewSell1.89K$65.30123.35K
2025-12-31Cittadine AndrewSell4.33K——
2025-12-26Vu Quan AnhBuy1.50K$69.95104.92K
2025-12-18KLAUSNER ARTHUR JSell4.66K$67.06312.50K
2025-12-18KLAUSNER ARTHUR JSell461$68.0931.39K
2025-12-16Hendricks DianeSell43.50K——
2025-12-16KLAUSNER ARTHUR JBuy7.71K——
2025-12-02Cittadine AndrewBuy13.92K——
2025-12-02Cittadine AndrewBuy8.97K$75.94681.11K
2025-12-02STARR CHRISTOPHER MBuy2.92K$75.94222.05K
2025-12-02KLAUSNER ARTHUR JBuy2.92K$75.94222.05K
2025-12-02Anderson RaymondBuy2.92K$75.94222.05K
2025-12-02Talukdar LavinaBuy2.92K$75.94222.05K
2025-12-02Tsuchimoto Kim RBuy2.92K$75.94222.05K
2025-12-02Vu Quan AnhBuy9.83K——
2025-12-02Vu Quan AnhBuy7.13K$75.94541.83K
2025-12-02Robinson ChandlerBuy49.13K——
2025-12-02Robinson ChandlerBuy16.75K$75.941.27M
2025-09-30Cittadine AndrewBuy4.33K——
2025-09-30Cittadine AndrewSell1.90K$81.67154.85K
2025-09-30Cittadine AndrewSell4.33K——
2025-09-30Robinson ChandlerBuy8.73K——
2025-09-30Robinson ChandlerSell2.65K$81.67216.10K
2025-09-30Robinson ChandlerSell8.73K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 98, holders +16 vs prior quarter. Ownership 73.00%.

HolderSharesChangeChange %Value
JUPITER TOPCO LLC1.31M1.31MNew121.70M
RA CAPITAL MANAGEMENT, L.P.667.21K00.00%61.78M
BLACKROCK, INC.348.82K32.25K+10.19%32.30M
DEERFIELD MANAGEMENT COMPANY, L.P.323.75K00.00%29.98M
SATURN V CAPITAL MANAGEMENT LP311.98K-33.65K-9.74%28.89M
SIREN, L.L.C.270.12K00.00%25.01M
ADAR1 CAPITAL MANAGEMENT, LLC217.59K-46.68K-17.66%20.15M
POLAR CAPITAL HOLDINGS PLC214.47K-12.06K-5.32%19.86M
VANGUARD CAPITAL MANAGEMENT LLC209.71K-8.75K-4.01%19.42M
ADAGE CAPITAL PARTNERS GP, L.L.C.209.19K-100.00K-32.34%19.37M
TCG CROSSOVER MANAGEMENT, LLC203.33K71.22K+53.92%18.83M
WELLINGTON MANAGEMENT GROUP LLP158.44K-15.90K-9.12%14.67M
ORBIMED ADVISORS LLC157.42K157.42KNew14.58M
CANDRIAM S.C.A.143.34K143.34KNew13.26M
BALYASNY ASSET MANAGEMENT L.P.134.54K-1.90K-1.39%12.46M
GEODE CAPITAL MANAGEMENT, LLC112.58K12.66K+12.67%10.43M
ALYESKA INVESTMENT GROUP, L.P.100.00K00.00%9.26M
STATE STREET CORP92.55K4.20K+4.75%8.57M
VIVO CAPITAL, LLC90.50K00.00%8.38M
DRIEHAUS CAPITAL MANAGEMENT LLC84.04K50.88K+153.47%7.78M
BANK OF NEW YORK MELLON CORP76.94K-1.68K-2.13%7.12M
VESTAL POINT CAPITAL, LP75.73K10.31K+15.76%7.01M
LONGAEVA PARTNERS L.P.55.83K55.83KNew5.17M
NEUBERGER BERMAN GROUP LLC55.19K12.76K+30.07%5.11M
MILLENNIUM MANAGEMENT LLC50.31K-2.64K-4.99%4.66M

Earnings and financials

Monopar Therapeutics Inc. (MNPR) trades at $70.82, with a market cap of $475.36M and a trailing P/E of -30.19. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
0000000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Monopar Therapeutics (MNPR) Financials: Revenue & Earnings

MNPR$70.82-1.02 -1.42%

$475.36M

Market Cap

-30.19

P/E

113.18

Forward P/E

—

Score

Price History